Here we go with another one. Three weeks ago, I mentioned in a post that the week of October 7 to 14 was declared by our very own United States Senate to be Naturopathic Medicine Week, which I declared unilaterally through my power as managing editor of Science-Based Medicine (for what that’s worth) to be […]
Category: Clinical trials
In medicine, particularly oncology, it’s often the little things that matter. Sometimes, however, the “little things” aren’t actually little; they just seem that way. I was reminded of this by a story that was circulating a couple of weeks ago in the national media, often under titles like “Obese cancer patients often shorted on chemo […]
Share this:
Tomorrow, as mandated by the Patient Protection and the Affordable Care Act (PPACA, often called just the Affordable Care Act, or ACA, or “Obamacare”), the government-maintained health insurance exchanges will open for business (that is, assuming the likely government shutdown doesn’t stop them temporarily). This post will be basically a followup to a post I […]
Share this:
I’ve written a lot about Stanislaw Burzynski and what I consider to be his unethical use and abuse of institutional review boards and clinical trials. Before that, I used to regularly write about Mark and David Geier and their unethical use and abuse of IRBs and clinical trials. In both cases, I lamented how they […]
Share this:
About a week and a half ago, I wrote about a local oncologist who was arrested by the FBI for massive Medicare fraud in which physician involved diagnosed cancers that weren’t there, gave chemotherapy to patients who either didn’t have cancer or were in remission and thus didn’t need it, and had developed a self-referral […]
